Aims: To compare the pharmacodynamics of cisatracurium and rocuronium-induced neuromuscular block follow-ing single dose, allowing either spontaneous or neostigmine-accelerated complete recovery. Methods: Following the ethics committee approval and informed consent, 120 patients scheduled for elective surgery under TIVA with tracheal intubation were randomized into 4 groups with different cisatracurium (CIS, 0.10 or 0.15 mg.kg–1) or rocuronium (ROC, 0.60 or 0.90 mg.kg–1) doses administered. For each patient, the onset time for 95 % depression of T 1, clinical duration until 25 % recovery, recovery index (
Background Reversal of the residual effect of rocuronium or cisatracurium by neostigmine may be slow...
Background Reversal of the residual effect of rocuronium or cisatracurium by neostigmine may be slow...
Study Objective: To evaluate the time course of action, dose requirement, reversibility, and pharmac...
This study was designed to compare the variability of the onset and offset of the effect of two neur...
The aim of this study was to compare the time course characteristics of cisatracurium (C) and vecuro...
The aim of this study was to compare the time course characteristics of cisatracurium (C) and vecuro...
The aim of this study was to compare the time course characteristics of cisatracurium (C) and vecuro...
Study objective To demonstrate the effect of administering a precurarizing dose of cisatracurium or ...
We studied the time-course of action of atracurium 0.5 mg kg-1 and rocuronium 0.6 mg kg-1 in 24 heal...
Background and aim: Neuromuscular monitoring has decreased the incidence of post-operative residual ...
Background: Neuromuscular-blocking drugs block neuromuscular transmission, causing paralysis of the ...
Study Objective: To evaluate the time course of action, dose requirement, reversibility, and pharmac...
Study Objective: To evaluate the time course of action, dose requirement, reversibility, and pharmac...
Study Objective: To evaluate the time course of action, dose requirement, reversibility, and pharmac...
Background Reversal of the residual effect of rocuronium or cisatracurium by neostigmine may be slow...
Background Reversal of the residual effect of rocuronium or cisatracurium by neostigmine may be slow...
Background Reversal of the residual effect of rocuronium or cisatracurium by neostigmine may be slow...
Study Objective: To evaluate the time course of action, dose requirement, reversibility, and pharmac...
This study was designed to compare the variability of the onset and offset of the effect of two neur...
The aim of this study was to compare the time course characteristics of cisatracurium (C) and vecuro...
The aim of this study was to compare the time course characteristics of cisatracurium (C) and vecuro...
The aim of this study was to compare the time course characteristics of cisatracurium (C) and vecuro...
Study objective To demonstrate the effect of administering a precurarizing dose of cisatracurium or ...
We studied the time-course of action of atracurium 0.5 mg kg-1 and rocuronium 0.6 mg kg-1 in 24 heal...
Background and aim: Neuromuscular monitoring has decreased the incidence of post-operative residual ...
Background: Neuromuscular-blocking drugs block neuromuscular transmission, causing paralysis of the ...
Study Objective: To evaluate the time course of action, dose requirement, reversibility, and pharmac...
Study Objective: To evaluate the time course of action, dose requirement, reversibility, and pharmac...
Study Objective: To evaluate the time course of action, dose requirement, reversibility, and pharmac...
Background Reversal of the residual effect of rocuronium or cisatracurium by neostigmine may be slow...
Background Reversal of the residual effect of rocuronium or cisatracurium by neostigmine may be slow...
Background Reversal of the residual effect of rocuronium or cisatracurium by neostigmine may be slow...
Study Objective: To evaluate the time course of action, dose requirement, reversibility, and pharmac...